Skip to main content

Animations

MJFF Publications

41 - 50 of 8808 Results
Title
Year
  • Year
  • 2018
  • 2021
  • 2015
  • 2014
  • 2011
  • 2023
  • 2023
  • 2021
  • 2016
  • 2018
  • Summary Details
    RESTRICTED
    Title: Toward defining deep brain stimulation targets in MNI space: A subcortical atlas based on multimodal MRI, histology and structural connectivity
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.05.015
    Citation Count: 428
  • Summary Details
    RESTRICTED
    Title: Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000012868
    Citation Count: 68
  • Summary Details
    RESTRICTED
    Title: The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson’s disease
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2014.09.049
    Citation Count: 111
  • Summary Details
    RESTRICTED
    Title: Therapy for Parkinson’s Disease: What is in the Pipeline?
    Journal Name: Neurotherapeutics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s13311-013-0242-1
    Citation Count: 20
  • Summary Details
    RESTRICTED
    Title: Regulation of myocyte enhancer factor-2 transcription factors by neurotoxins
    Journal Name: NeuroToxicology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuro.2011.05.019
    Citation Count: 15
  • Summary Details
    RESTRICTED
    Title: Perspective on the current state of the LRRK2 field
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00544-7
    Citation Count: 11
  • Summary Details
    RESTRICTED
    Title: Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00535-8
    Citation Count: 9
  • Summary Details
    RESTRICTED
    Title: Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00203-9
    Citation Count: 83
  • Summary Details
    RESTRICTED
    Title: Autosomal dominant Parkinson's disease caused by SNCA duplications
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.09.007
    Citation Count: 151
  • Summary Details
    RESTRICTED
    Title: Unlocking the mystery of biomarkers: A brief introduction, challenges and opportunities in Parkinson Disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.07.021
    Citation Count: 14
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.